FindTrial
Sign In

A clinical study of treatment for concomitant severe esophageal or gastric varices in patients with hepatocellular carcinoma

A clinical study of treatment for concomitant severe esophageal or gastric varices in patients with hepatocellular carcinoma

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-TRC-10001044
Enrollment
Unknown
Registered
2010-10-05
Start date
2008-09-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hepatocellular carcinoma

Interventions

A:periesophagogastric devascularization+resection of HCC
B:periesophagogastric devascularization+delay resection of HCC
C:periesophagogastric devascularization+TACE
D:periesophagogastric devascularization+PRFA

Sponsors

Eastern Hepatobiliary Surgery Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1. 18-70 years old, male or female; 2. Clinical diagnosis is "hepatocellular carcinoma(HCC); concomitant severe esophageal or gastric varices"; 3. Patients have history of upper gastrointestinal bleeding or tendency of upper gastrointestinal bleeding by gastroscopy; 4. Liver function is Child-Pugh A or B.

Exclusion criteria

Exclusion criteria: 1. Patients are not willing to receive treatment; 2. Patients can not be follow-up; 3. Patients have servere damage of the heart, lung or kidney function or extrahepatic metabasis.

Design outcomes

Primary

MeasureTime frame
over-all survival;—

Countries

China

Contacts

Public ContactYan Yiqun
ehbhyyq@163.com+86 021 81875501

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026